$aartipharmabounce or die zone here added since my earlier entry was messed up on it and i recon this should run it back so long term play for me close below H4 200 ema no bueno and opens up the door for red line below Longby CompoundingGain0
Aarti Pharma labs-Nice BreakoutAarti Pharma labs-Nice Breakout Capital to be deployed -20k Investing Price-675-685 Breakout Price -669 Stoploss -559 Targets -1150 #chennai #StockMarketindia #StockToWatch #StocksInFocus #stockstowatch #StocksToTrade #aartipharmalabsLongby Microcap_Investor0
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Register adviser, please take advise from your financial adviser before investing in any stocks. Stock has given break out , buy above the High and do not forget to keep stop loss best suitable for swing trading. Keep this stock in watch list. Target and Stop loss Shown on Chart. As stop loss is Big we keep Target 1:1 Be Discipline, because discipline is the key to Success in Stock Market. Trade what you See Not what you Think.by AnsariTV2
Aarti Pharmalabs Limited (APL) BreakoutSector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln Median PE:-34.9 EPS in Rs:-24.86 NOTE:- All the information provided is for educational and informational purposes only. . I am NOT a SEBI registered advisor or a financial adviser.Longby varunmp20872
AARTIPHARMSupport and Resistance Levels: In technical analysis, support and resistance levels are significant price levels where buying or selling interest tends to be strong. They are identified based on previous price levels where the price has shown a tendency to reverse or find support.by akilan147932
Aarti Pharmalabs Ltd TARGET AND STOPLOSS IN CHART Market Cap ₹ 4,170 Cr. Current Price ₹ 460 High / Low ₹ 476 / 235 Stock P/E 22.0 Book Value ₹ 183 Dividend Yield 0.00 % ROCE 16.1 % ROE 13.2 % Face Value ₹ 5.00 Promoter holding 46.3 % EPS last year ₹ 21.4 EPS latest quarter ₹ 5.72 Debt ₹ 207 Cr. Pledged percentage 0.00 % Net CF ₹ -58.3 Cr. Price to Cash Flow 15.8 Free Cash Flow ₹ 143 Cr. Debt to equity 0.12 OPM last year 17.6 % Reserves ₹ 1,612 Cr. Price to book value 2.51 Int Coverage 14.2 Price to Sales 2.25 Longby madhu28113
📈 Analysis of AARTIPHARM: A Bullish Opportunity Awaits? 📈Hello, fellow traders! 👋 Today's spotlight is on AARTIPHARM . After closely observing its four-hour time frame, here's what caught my attention: 1️⃣ Major Trend: The stock is confidently striding in an upward direction. Each stride it takes, it glances back at its support, reassuring itself before surging upwards again. 2️⃣ Pattern Recognition: The recurring 'higher high' formation suggests a consistent bullish behavior. 3️⃣ Support Check: It's gearing up to greet its support level once again. A friendly wave or a hug? Let's find out! 4️⃣ Moving Average: The 200-day moving average is waving right at its entry price. A potential bullish beacon? 5️⃣ Upward Direction: This can be the wind beneath our trading wings, providing additional strength for our strategies. 🚀 Takeaway: All these factors hint towards a trade opportunity that we might not want to miss. But as always, tread with caution and ensure your research backs your moves. ❓ Your Thoughts: Have you been tracking AARTIPHARM? What's your take on its current position? Drop your insights below! 🔔 Stay Tuned: I'll be back with more insights and analyses. Don't forget to follow for timely updates. Until the next trade, keep those charts ringing and strategies sharp! 📊 Warm regards, Alpha Trading StationLongby AlphaTradingStationUpdated 2
AARTIPHARMALAB short term target 525AARTIPHARMALAB breakout retest done. short term target 525Longby sanjeevcmail3
Base on Base breakout the stock retested after a base-on-base consolidation, the stock broke out with huge volume and decent fallow up with good volume is a good sign to enter the stock.Longby Mohank230